Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411305 · ClinicalTrials.gov registry record
Feasibility Testing of the Quality-monitoring Tool, Qdact, for the Palliative Care Research Cooperative
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 40
- Enrollment target
NCT02411305 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 40 participants.
The verdict
NCT02411305 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Few formal mechanisms for collecting, analyzing, and reporting data on quality in palliative care exist. Such infrastructure is needed to understand current clinical practices, inform quality improvement projects, and research which links adherence to specific quality measures and improved patient-centered outcomes. This infrastructure, if proven feasible, can then become integrated into usual palliative care delivery across the PCRC. Then, palliative care can conduct the same types of collaborative quality improvement activities, based on data collected at point of care, as other medical disciplines like general surgery and cardiology.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02411305
The ClinicalTrials.gov registry entry for NCT02411305 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02411305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02411305 about?
NCT02411305 is a clinical study titled "Feasibility Testing of the Quality-monitoring Tool, Qdact, for the Palliative Care Research Cooperative". Few formal mechanisms for collecting, analyzing, and reporting data on quality in palliative care exist. Such infrastructure is needed to understand current clinical practices, inform quality improvement projects, and research which links adherence to specific quality measures and improved patient-c...
What is the current status of trial NCT02411305?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2015-02.
Who is sponsoring clinical trial NCT02411305?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.